MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.
Sign Up to like & getrecommendations! Published in 2021 at "Leukemia research"
DOI: 10.1016/j.leukres.2021.106516
Abstract: BACKGROUND Treatment-free survival (TFS) in chronic myeloid leukemia (CML) is a new goal. This prospective study aims to evaluate imatinib discontinuation's feasibility and safety in patients with deep molecular response MR4 (BCR-ABL1 < 0.01 %… read more here.
Keywords: discontinuation results; median time; relapse; discontinuation ... See more keywords
WTP7.07 Evaluating Laparoscopic Competence: Insights from a Surgical Residents Competition
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Surgery"
DOI: 10.1093/bjs/znaf166.388
Abstract: To assess the laparoscopic skills of General surgery residents. A laparoscopic skills competition was organised for 21 residents at the Department of Surgery, Participants had two months of access to a simulator lab before an… read more here.
Keywords: median time; sec range; sec; sec passed ... See more keywords
Adherence to Pediatric Sepsis Treatment Recommendations at Emergency Departments
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Emergency Care"
DOI: 10.1097/pec.0000000000002801
Abstract: Objective Sepsis is one of the most urgent health care issues worldwide. Guidelines for early identification and treatment are essential to decrease sepsis-related mortality. Our aim was to collect data on the epidemiology of pediatric… read more here.
Keywords: sepsis; emergency; adherence; treatment ... See more keywords
Radiation Oncology Orals
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Medical Imaging and Radiation Oncology"
DOI: 10.1111/1754-9485.13780
Abstract: Purpose: Equitable healthcare and radiation therapy (RT) provision to rural and regional Australia remains a challenge. 1 For non-small-cell lung cancer (NSCLC), an Australian optimal care pathway has been published, recommending no more than 9… read more here.
Keywords: oncology; days iqr; radiation oncology; median time ... See more keywords
Protein-losing enteropathy recurrence after pediatric heart transplantation: Multicenter case series.
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric transplantation"
DOI: 10.1111/petr.14295
Abstract: BACKGROUND Protein-losing enteropathy (PLE) is a devastating complication of the Fontan circulation. Although orthotopic heart transplantation (HTx) typically results in resolution of PLE symptoms, isolated cases of PLE relapse have been described after HTx. METHODS… read more here.
Keywords: ple; protein losing; transplantation; htx ... See more keywords
Community-based multiple screening for metabolic syndrome by innovative theory: A longitudinal study.
Sign Up to like & getrecommendations! Published in 2022 at "Public health nursing"
DOI: 10.1111/phn.13033
Abstract: The purpose of this research is to elucidate whether metabolic syndrome affects the rate of adoption of a new multiple cancer screening programme, based on the Diffusion of Innovation theory. The time to attend the… read more here.
Keywords: theory; disease; metabolic syndrome; study ... See more keywords
P122 Treatment with rituximab to demand in rheumatoid arthritis. effectiveness analysis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-ewrr2018.137
Abstract: Introduction Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been shown to be effective in the treatment of rheumatoid arthritis (RA). At present we have different treatment regimens in terms of the time… read more here.
Keywords: treatment; median time; time; months months ... See more keywords
Diagnosis and management of secondary epipapillary retinoblastoma
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2016-309899
Abstract: Background Reports on retinoblastoma relapse at the optic nerve head (ONH) are anecdotal and include only treatments by external beam radiotherapy (EBRT) or enucleation. We aimed to describe such cases, termed secondary epipapillary retinoblastoma, diagnosed… read more here.
Keywords: secondary epipapillary; diagnosis; epipapillary retinoblastoma; hhsd oct ... See more keywords
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
Sign Up to like & getrecommendations! Published in 2024 at "Acta Haematologica"
DOI: 10.1159/000539587
Abstract: Abstract Introduction: Pirtobrutinib, a highly selective, noncovalent (reversible) Bruton tyrosine kinase inhibitor, has demonstrated promising efficacy in B-cell malignancies and is associated with low rates of discontinuation and dose reduction. Pirtobrutinib is administered until disease… read more here.
Keywords: exposure; treatment; median time; safety ... See more keywords
Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117293
Abstract: Introduction Allogeneic stem cell transplantation (allo-HCT) survivors are at a defined relevant risk of developing long-term complications: the prevalence of chronic health conditions approaches 75% among HCT survivors. The endocrine system is one of the… read more here.
Keywords: diagnosis; treatment; median time; time ... See more keywords
Germline alterations of hematopoietic growth factor receptors and maladaptive somatic genetic rescue leads to myeloid neoplasia
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5614
Abstract: Using rationally targeted NGS screen, we have previously identified germ line (GL) alteration in genes linked to hereditary bone marrow disease in 5% of myeloid neoplasia (MN) and 10% of bone marrow failure (BMF).1 In… read more here.
Keywords: csf3r; evolution; median time; bmf ... See more keywords